the present invention is directed to novel imidazolidin - 2 - one derivatives having a structure according to formula i wherein a , b , r 1 , r 2 , r 3 , and r 4 are as defined above , pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor .